Sichuan Kelun Pharmaceutical (002422.SZ): Injection of Alipazone Obtains Drug Registration Approval.

Kolon Pharmaceutical (002422.SZ) announced that its subsidiary Hunan Kolon Pharmaceutical Co., Ltd. recently received drug registration approval from the National Medical Products Administration for the chemical drug "Aripiprazole for Injection". Aripiprazole is a second generation atypical antipsychotic drug, the world's first approved dopamine D2 receptor partial agonist and dopamine system stabilizer. It can simultaneously relieve positive and negative symptoms, with milder side effects such as extrapyramidal symptoms and weight gain, making it one of the most commonly used antipsychotic drugs in clinical practice both domestically and internationally.